共 14 条
[1]
Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in Hemodialysis Patients with Atrial Fibrillation: A Multicenter Randomized Controlled Trial
[J].
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY,
2021, 32 (06)
:1474-1483
[2]
Multicenter Randomized Controlled Trial of Vitamin K Antagonist Replacement by Rivaroxaban with or without Vitamin K2 in Hemodialysis Patients with Atrial Fibrillation: the Valkyrie Study
[J].
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY,
2020, 31 (01)
:186-196
[5]
Hindricks G, 2021, EUR HEART J, V42, P546, DOI [10.1093/eurheartj/ehaa945, 10.1093/eurheartj/ehaa612]
[7]
January CT, 2019, J AM COLL CARDIOL, V74, P104, DOI [10.1161/CIR.0000000000000665, 10.1016/j.jacc.2019.01.011]